Vivani Medical, Inc. Accounts Receivable, Allowance for Credit Loss
Vivani Medical, Inc. (VANI) had Accounts Receivable, Allowance for Credit Loss of $117.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2021-03-16
- 2020-12-31: Accounts Receivable, Allowance for Credit Loss $117.00K.
- 2019-12-31: Accounts Receivable, Allowance for Credit Loss $117.00K.
- 2019-09-30: Accounts Receivable, Allowance for Credit Loss $117.00K.
- 2019-06-30: Accounts Receivable, Allowance for Credit Loss $115.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2020-12-31 | $117.00K 10-K · filed 2021-03-16 | |
| 2019-12-31 | $117.00K 10-K · filed 2021-03-16 | |
| 2019-09-30 | $117.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $115.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $180.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $181.00K 10-K · filed 2021-03-16 | |
| 2017-12-31 | $74.00K 10-K · filed 2020-03-19 | |
| 2016-12-31 | $212.00K 10-K · filed 2019-03-19 | $213.00K 10-K · filed 2017-03-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |